Professor John Deanfield: key facts
- Kind of voice
- Academic
- Role
- Professor, University College London Institute of Cardiovascular Science
- Quoted on
- Public health & prevention, Heart disease & stroke
- Press citations held
- 2
- Most recently quoted
- 10 Sept 2026
“Abdominal fat is more dangerous for our cardiovascular health than overall weight and therefore it is not surprising to see a link between reduction in waist size and cardiovascular benefit. However, this still leaves two-thirds of the heart benefits of semaglutide unexplained. These findings reframe what we think this medication is doing.”
What Professor John Deanfield has said
“Abdominal fat is more dangerous for our cardiovascular health than overall weight and therefore it is not surprising to see a link between reduction in waist size and cardiovascular benefit. However, this still leaves two thirds of the heart benefits of semaglutide unexplained. These findings reframe what we think this medication is doing.”
Professor, University College London Institute of Cardiovascular Science · Heart disease & stroke · 10 Sept 2026 · Semaglutide has heart benefits regardless of weight loss, research finds ↗
Where Professor John Deanfield has been quoted
- Weight-loss drug cuts heart attack risk regardless of kilograms shed, study findstheguardian.com · 10 Sept 2026
- Semaglutide has heart benefits regardless of weight loss, research findspulsetoday.co.uk · 10 Sept 2026
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.